Session Details

U101 JAAD and Beyond: The Best Articles of the Year

Mon, Mar 10, 4:30 PM - 5:30 PM
W311A
1 CME Available Focus Session
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Cutting-edge advances published in JAAD, JAMA Derm, EADV and BJD will be presented with a discussion of why they are game changers.

LEARNING OBJECTIVES

1.

Review treatment updates from the JAAD, JAMA Derm, EADV and BJD.

2.

Discuss diagnostic updates from the JAAD, JAMA Derm, EADV and BJD.

SCHEDULE

8:30 PM

The best articles from the BJD

Aaron Mark Drucker, MD, FAAD

8:40 PM

The best articles from JAMA Derm

Kanade Shinkai, MD, PhD, FAAD

8:50 PM

The best articles from JEADV

Carle F. Paul, MD, IFAAD

9:00 PM

The best articles from IJD

Lajos Kemeny, PhD, MD, DSc, IFAAD

9:10 PM

The best articles from JAAD

Dirk Michael Elston, MD, FAAD

9:20 PM

Q&A

SPEAKERS

Aaron Mark Drucker, MD, FAAD

Aaron Mark Drucker, MD, FAAD

Dirk Michael Elston, MD, FAAD

Dirk Michael Elston, MD, FAAD

Lajos Kemeny, PhD, MD, DSc, IFAAD

Lajos Kemeny, PhD, MD, DSc, IFAAD

Carle F. Paul, MD, IFAAD

Carle F. Paul, MD, IFAAD

Kanade Shinkai, MD, PhD, FAAD

Kanade Shinkai, MD, PhD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Aaron Mark Drucker, MD, FAAD

No financial relationships exist with ineligible companies.

Dirk Michael Elston, MD, FAAD

No financial relationships exist with ineligible companies.

Lajos Kemeny, PhD, MD, DSc, IFAAD

AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Eli-Lilly – Advisory Board(Honoraria); Eli-Lilly Ltd – Advisory Board(Honoraria); Janssen-Cilag – Advisory Board(Honoraria), Speaker(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria);

Carle F. Paul, MD, IFAAD

AbbVie – Consultant(Honoraria); Amgen – Consultant(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Celgene – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria); Galderma Global – Consultant(Honoraria); IQVIA – Data Safety Monitoring Board(Honoraria); Janssen-Cilag – Consultant(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Merck – Consultant(Honoraria); Mylan Technologies Inc. – Consultant(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Consultant(Honoraria); Pierre Fabre Dermo Cosmetique France – Consultant(Honoraria); Sanofi/Regeneron – Consultant(Honoraria);

Kanade Shinkai, MD, PhD, FAAD

No financial relationships exist with ineligible companies.